In cancers of men, prostate cancer (PCa) is a prevalent malignancy. Finding biomarkers is important and useful for figuring out PCa incidence and prognosis. For males over 50, prostate cancer (PCa) is the most prevalent adenocarcinoma type of cancer diagnosis. PCa typically has a variety of clinical and pathological symptoms and is heterogeneous and multifocal. There is currently little knowledge about the molecular genetics of the progression mechanism behind this variability. The most effectiv...

Colorectal cancer is a worldwide health issue with high-cost treatment process. Several experimental studies have clarified the role of Hepcidin as a new reliable marker that helps to predict colorectal cancer development and prognosis. Our study Aims to measure Hepcidin levels in patients diagnosed with colorectal cancer, study the importance of Hepcidin levels and its correlation with recurrence....

This comprehensive review explores the multifaceted relationship between neoadjuvant immunotherapy, intestinal microbiota alterations, and anastomotic leakage risk in patients undergoing colectomy for colon neoplasia. With the advent of immunotherapy, remarkably immune checkpoint inhibitors, there has been a significant shift in the treatment paradigms for various cancers, including colon neoplasia. These treatments, while effective, have been associated with changes in the intestinal microbiome...